ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

St. Jude Offers Three Fellowships

March 2, 1984

New Research Grant Awards

December 13, 1974

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998

DRCCA Board Votes To Pull NCI Out Of Joint Program With OSHA For Workplace Education And Prevention

January 29, 1982

In Brief: Cancer Patient Said To Face Job Discrimination; A Goal Of New Epidemiology College: Certification

April 30, 1982

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013